X-67545316-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_000044.6(AR):​c.210_239dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA​(p.Gln71_Gln80dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q80Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00077 ( 0 hom., 5 hem., cov: 0)
Exomes 𝑓: 0.00034 ( 0 hom. 24 hem. )
Failed GnomAD Quality Control

Consequence

AR
NM_000044.6 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.337

Publications

10 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-T-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA is Benign according to our data. Variant chrX-67545316-T-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 420189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.210_239dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln71_Gln80dup disruptive_inframe_insertion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.210_239dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln71_Gln80dup disruptive_inframe_insertion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.000750
AC:
50
AN:
66636
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000373
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000383
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00162
Gnomad SAS
AF:
0.00110
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00107
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000343
AC:
321
AN:
937045
Hom.:
0
Cov.:
40
AF XY:
0.0000813
AC XY:
24
AN XY:
295187
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000168
AC:
4
AN:
23760
American (AMR)
AF:
0.000967
AC:
25
AN:
25850
Ashkenazi Jewish (ASJ)
AF:
0.000369
AC:
6
AN:
16267
East Asian (EAS)
AF:
0.00166
AC:
47
AN:
28342
South Asian (SAS)
AF:
0.000487
AC:
22
AN:
45195
European-Finnish (FIN)
AF:
0.000442
AC:
16
AN:
36188
Middle Eastern (MID)
AF:
0.00116
AC:
3
AN:
2596
European-Non Finnish (NFE)
AF:
0.000256
AC:
184
AN:
718962
Other (OTH)
AF:
0.000351
AC:
14
AN:
39885
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.367
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000766
AC:
51
AN:
66623
Hom.:
0
Cov.:
0
AF XY:
0.000605
AC XY:
5
AN XY:
8259
show subpopulations
African (AFR)
AF:
0.000372
AC:
7
AN:
18799
American (AMR)
AF:
0.000382
AC:
2
AN:
5236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1715
East Asian (EAS)
AF:
0.00163
AC:
3
AN:
1843
South Asian (SAS)
AF:
0.00111
AC:
1
AN:
901
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2025
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
133
European-Non Finnish (NFE)
AF:
0.00109
AC:
38
AN:
34713
Other (OTH)
AF:
0.00
AC:
0
AN:
812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.589
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AR: BS2 -

Jul 24, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 2062380) -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.34
Mutation Taster
=69/31
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3032358; hg19: chrX-66765158; API